Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A transcriptomics dataset from a 2026 study investigating the role of Dipeptidyl peptidase 4 (DPP4) in Metabolic dysfunction-associated steatotic liver disease (MAFLD). The data contains gene expression changes in human induced pluripotent stem cell-derived hepatocyte-like cells under steatosis conditions and after treatment with the DPP4 inhibitor vildagliptin. The dataset was authored by Christiane Loerch and shared under a CC-BY-4.0 license.
Data is in XLSX format, requiring software like Excel or a compatible library to open.